Seaport Therapeutics

Seaport Therapeutics Names Lauren White as Chief Financial Officer

November 5, 2024 – Boston, MA, US – Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the appointment of Lauren White as Chief Financial Officer. An accomplished biotech financial executive, Ms. White most recently served as the Chief Financial...
6 Tide Street, Suite 400, Seaport Boston, MA 02210